why precision medicine matters

why precision medicine matters

when we talk about mutations, this represents a very small amount of cancer patients – in colorectal cancer for example, mutations in NTRK, MSI-h/dMMR, and BRAF are considered rare [1%, 15%, 9% respectively].  however, this actually represents respectively-...

the importance of biomarker testing

over the last two weeks we’ve shared lots of information about biomarkers and targeted therapies – but what does it all really mean?  we wanted to show how important molecular profiling/biomarker testing is to guide treatment planning for patients. these...